The Republic of Iceland – Government Debt Management
3.2.2021 16:32:27 CET | Globenewswire | Press release
| Series | RIKB 31 0124 | RIKS 26 0216 |
| ISIN | IS0000020386 | IS0000030732 |
| Maturity Date | 01/24/2031 | 02/16/2026 |
| Auction Date | 02/05/2021 | 02/05/2021 |
| Settlement Date | 02/10/2021 | 02/10/2021 |
| 10% addition | 02/09/2021 | 02/09/2021 |
On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bonds in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bonds must be received by the Central Bank before 14:00 on the Settlement Date, and the Bonds will be delivered in electronic form on the same day. Article 6 of the General Terms of Auction for Treasury bonds applies for the right to purchase an additional 10%.
Further reference is made to the description of the Treasury bond and the General Terms of Auction for Treasury bonds on the Government Debt Management website.
For additional information please contact Oddgeir Gunnarsson, Government Debt Management, at +354 569 9635.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Standard Lithium30.3.2026 14:00:00 CEST | Press release
Standard Lithium Reports Fourth Quarter and Full Year 2025 Results
Chiesi Global Rare Diseases30.3.2026 14:00:00 CEST | Press release
Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
Evaxion30.3.2026 14:00:00 CEST | Press release
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
Teva Pharmaceutical Industries Ltd30.3.2026 14:00:00 CEST | Press release
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Novo Nordisk A/S30.3.2026 13:48:51 CEST | Press release
Novo Nordisk A/S - share repurchase programme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
